Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

241
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
241
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

434
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
434
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

176
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
176

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries.

European urology·2026
Same author

How to benchmark medical AI agents.

PLoS medicine·2026
Same author

Mechanisms of Progression and Challenges for Intervention in the Natural History of Early Prostate Cancer: A Narrative Review.

Current oncology (Toronto, Ont.)·2026
Same author

Causal inference and digital twins: a roadmap for the future of clinical trials.

NPJ digital medicine·2026
Same author

Translation readiness of model-based synthetic tabular data in healthcare: a systematic review and governance audit.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE Trials.

European urology oncology·2026

Related Experiment Video

Updated: Sep 2, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate

Changhee Lee1, Alexander Light2, Evgeny S Saveliev3

  • 1Department of Artificial Intelligence, Chung-Ang University, Seoul, South Korea.

NPJ Digital Medicine
|August 6, 2022
PubMed
Summary

A new deep learning model improves prostate cancer active surveillance by predicting progression risk with increasing accuracy over time. This machine learning approach offers personalized follow-up for better patient management.

More Related Videos

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

178
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Related Experiment Videos

Last Updated: Sep 2, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

178
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Area of Science:

  • Oncology
  • Medical Informatics
  • Machine Learning

Background:

  • Active Surveillance (AS) is a prostate cancer management strategy involving continuous monitoring for disease progression.
  • Current AS lacks robust methods for real-time updates on individual progression risk.
  • This gap necessitates advanced predictive modeling for personalized patient care.

Purpose of the Study:

  • To develop and validate a novel deep learning model for predicting prostate cancer progression during AS.
  • To enhance the accuracy of risk prediction by incorporating longitudinal follow-up data.
  • To identify distinct patient subgroups with similar progression trajectories.

Main Methods:

  • Development of a Dynamic-DeepHit-Lite (DDHL) model, a deep learning-based longitudinal survival model.
  • Application of Actor-Critic temporal predictive clustering (AC-TPC) to identify outcome-related patient clusters.
  • Validation using data from 585 men on AS with a median follow-up of 4.4 years.
  • Comparison of DDHL model performance against Cox regression and landmarking methods using C-indices and Brier scores.

Main Results:

  • The DDHL model demonstrated improved predictive performance with additional follow-up data compared to baseline models.
  • With 3 years of data and follow-up, DDHL achieved a C-index of 0.79, outperforming landmarking Cox (0.70) and baseline Cox (0.67).
  • AC-TPC identified 4 distinct temporal clusters, with progression risks ranging from negligible to 50% by 5 years in the highest-risk group.

Conclusions:

  • A novel machine learning approach, DDHL combined with AC-TPC, significantly enhances personalized follow-up for prostate cancer AS.
  • The model's predictive power increases with more longitudinal data, offering dynamic risk assessment.
  • This approach supports tailored clinical decisions by identifying patients with varying progression risks.